Merck Kgaa

Architects' plans for the 16,000 sq metre EMD Serono site in Germany

Merck Serono invests €65m in bio R&D

By Fiona BARRY

Merck (EMD) Serono, the biopharmaceutical division of Merck KGaA, is building a €65m R&D lab for 200 staff in Darmstadt, Germany.

Merck Serono pledges €150m to biosimilars in 2015

Merck Serono pledges €150m to biosimilars in 2015

By Zachary Brennan

Merck Serono is planning to invest between €130m ($168m) and €150m ($194m) in biosimilars in 2015, depending on the outcome of ongoing Phase I studies, the company announced Thursday.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers